Filing Flows › Myomo (MYO) › Q2 2025
Myomo (MYO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 11, 2025
Myomo (MYO) reported revenue of $9.7M for the second quarter 2025 (Q2 2025), +28% from a year earlier and -2% from the quarter before. Operating margin was -47.6%, net loss $4.6M (48.0% of revenue).
Myomo, Q2 2025: revenue $9.7M (+28% year over year), operating margin -47.6%, net loss $4.6M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.7M | -2% | +28% |
| Operating profit | −$4.6M | — | — |
| Net earnings | −$4.6M | — | — |
| Operating cash flow | −$8.9M | — | — |
What changed
Revenue was $9.7M in Q2 2025, up 28% year over year and down 2% from the previous quarter.
Gross margin was 62.7%, down 8.1 points from a year earlier. Operating costs exceeded revenue by $4.6M, an operating margin of -47.6%. Operating expenses grew 65% against revenue growth of 28%. The fastest-growing cost line was Research & development (+99%). The quarter ended with a net loss of $4.6M, wider than the previous quarter's $3.5M loss.
Operating cash flow was −$8.9M. Non-cash charges added back $191K of depreciation and $395K of share-based compensation. Working capital and other items used $4.8M. Capital expenditures of $1.3M exceeded it, leaving free cash flow of −$10.1M.
Questions
What was Myomo's revenue in the second quarter 2025?
Myomo (MYO) reported revenue of $9.7M for the second quarter 2025 (Q2 2025), +28% from a year earlier and -2% from the quarter before.
Was Myomo profitable in the second quarter 2025?
Operating loss was $4.6M (-47.6% of revenue) and net loss $4.6M.
Source: Myomo 10-Q on SEC EDGAR.